Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Total article views   HTML views PDF downloads Totals
17,800 Dovepress* 15,077+ 1,509 16,586
PubMed Central* 2,723 618 3,341
Totals 17,800 2,127 19,927
*Since 5 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
20 1 0 1 5 13

View citations on PubMed Central and Google Scholar